OMKAR PHARMACHEM [OMKARPH] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

OMKAR PHARMACHEM LTD.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: OMKAR PHARMACHEM LTD. wins in 3 metrics, Gujarat Themis Biosyn Ltd. wins in 14 metrics, with 1 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric OMKAR PHARMACHEM LTD. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 327.78 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio 3.13 13.36 OMKAR PHARMACHEM LTD.
Debt-to-Equity Ratio 0.00 27.04 Tie
PEG Ratio -5.03 -17.55 OMKAR PHARMACHEM LTD.
EV/EBITDA 140.88 52.76 Gujarat Themis Biosyn Ltd.
Profit Margin (TTM) 16.73% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 37.71% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 37.71% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 2.13% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 2.09% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $2.40M $-251.22M OMKAR PHARMACHEM LTD.
Dividend Yield N/A 0.17% N/A
1-Year Return -3.09% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 58.34 22.23 Gujarat Themis Biosyn Ltd.
Enterprise Value $296.42M $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 58.12 22.65 Gujarat Themis Biosyn Ltd.
Gross Profit Margin (TTM) N/A 83.29% N/A
Revenue per Share (TTM) $1 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $0.09 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.10 -0.17 Gujarat Themis Biosyn Ltd.

OMKAR PHARMACHEM LTD. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

OMKARPH
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
OMKAR PHARMACHEM LTD.-4.99%-5.00%-8.49%-13.05%-9.46%-13.75%
Gujarat Themis Biosyn Ltd.1.72%7.42%6.10%33.40%-1.19%-10.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
OMKAR PHARMACHEM LTD.-3.09%8.00%35.68%344.81%413.31%581.82%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: OMKAR PHARMACHEM LTD. vs Gujarat Themis Biosyn Ltd.

MetricOMKARPHGUJTHEM
Market Information
Market Cap i₹297.55M₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i479,452
90 Day Avg. Volume i1106,446
Last Close₹24.37₹401.80
52 Week Range₹24.37 - ₹29.74₹225.05 - ₹479.00
% from 52W High-18.06%-16.12%
All-Time High₹30.09 (May 26, 2025)₹479.00 (Oct 27, 2025)
% from All-Time High-19.01%-16.12%
Growth Metrics
Quarterly Revenue Growth-0.22%0.10%
Quarterly Earnings Growth-0.65%-0.04%
Financial Health
Profit Margin (TTM) i0.17%0.30%
Operating Margin (TTM) i0.38%0.40%
Return on Equity (TTM) i0.02%0.20%
Debt to Equity (MRQ) i0.0027.04
Cash & Liquidity
Book Value per Share (MRQ)₹9.44₹24.29
Cash per Share (MRQ)₹0.06₹0.92
Operating Cash Flow (TTM) i₹2.44M₹970.68M
Levered Free Cash Flow (TTM) i₹2.01M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: OMKAR PHARMACHEM LTD. vs Gujarat Themis Biosyn Ltd.

MetricOMKARPH (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i327.7873.73
Forward P/E iN/AN/A
PEG Ratio i-5.03-17.55
Price to Sales (TTM) i58.3422.23
Price to Book (MRQ) i3.1313.36
Market Capitalization
Market Capitalization i₹297.55M₹35.41B
Enterprise Value i₹296.42M₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i58.1222.65
Enterprise to EBITDA i140.8852.76
Risk & Other Metrics
Beta i0.10-0.17
Book Value per Share (MRQ) i₹9.44₹24.29

Financial Statements Comparison: OMKAR PHARMACHEM LTD. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOMKARPH (2025)GUJTHEM (2025)
Revenue/Sales i5.40M1.51B
Cost of Goods Sold i0318.78M
COGS % of Revenue i0.0%21.1%
Gross Profit i5.40M1.19B
Gross Margin i100.0%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i2.86M642.49M
Operating Margin i53.0%42.6%
EBITDA i2.93M713.04M
EBITDA Margin i54.3%47.3%
Pre-Tax Income i2.70M655.38M
Pre-Tax Income % of Revenue i50.0%43.5%
Income Tax i691,000167.66M
Income Tax % of Revenue i12.8%11.1%
Net Income (Profit) i2.01M487.72M
Profit Margin i37.2%32.3%

Balance Sheet & Liquidity Metrics

MetricOMKARPH (2025)GUJTHEM (2025)
Cash & Equivalents i1.09M116.94M
Total Current Assets i2.65M519.73M
Total Current Assets % of Revenue i49.1%34.5%
Total Current Liabilities i1.70M205.60M
Total Current Liabilities % of Revenue i31.4%13.6%
Long-Term Debt i0296.36M
Long-Term Debt % of Revenue i0.0%19.7%
Total Shareholders Equity i94.34M2.48B
Retained Earnings i-6.50M2.37B
Retained Earnings % of Revenue i-120.4%157.4%
Property, Plant & Equipment i183,000411.30M

Cash Flow Statement Comparison

MetricOMKARPH (2025)GUJTHEM (2025)
Operating Cash Flow i2.44M970.68M
Operating Cash Flow % of Revenue i45.2%64.4%
Capital Expenditures i-40,000-1.16B
Free Cash Flow i2.40M-251.22M
FCF Margin i44.4%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOMKARPHGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.08M108.97M
Float Shares i4.97M29.52M
% Held by Insiders i51.14%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i48.86%26.84%

Dividend Analysis & Yield Comparison: OMKAR PHARMACHEM LTD. vs Gujarat Themis Biosyn Ltd.

MetricOMKARPHGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025